Cargando…
Myocardial and mitochondrial effects of the anhydrase carbonic inhibitor ethoxzolamide in ischemia‐reperfusion
We have previously demonstrated that inhibition of extracellularly oriented carbonic anhydrase (CA) isoforms protects the myocardium against ischemia‐reperfusion injury. In this study, our aim was to assess the possible further contribution of CA intracellular isoforms examining the actions of the h...
Autores principales: | Ciocci Pardo, Alejandro, González Arbeláez, Luisa F., Fantinelli, Juliana C., Álvarez, Bernardo V., Mosca, Susana M., Swenson, Erik R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606860/ https://www.ncbi.nlm.nih.gov/pubmed/34806317 http://dx.doi.org/10.14814/phy2.15093 |
Ejemplares similares
-
Intrinsic thermodynamics of ethoxzolamide inhibitor binding to human carbonic anhydrase XIII
por: Baranauskienė, Lina, et al.
Publicado: (2012) -
Antioxidant Activity and Cardioprotective Effect of a Nonalcoholic Extract of Vaccinium meridionale Swartz during Ischemia-Reperfusion in Rats
por: Lopera, Yasmin E., et al.
Publicado: (2013) -
Is N-methylacetazolamide a possible new therapy against ischemia-reperfusion injury?
por: Pardo, Alejandro Ciocci, et al.
Publicado: (2023) -
Anti-Helicobacter pylori activity of ethoxzolamide
por: Modak, Joyanta K., et al.
Publicado: (2019) -
Antibacterial activity of ethoxzolamide against Helicobacter pylori strains SS1 and 26695
por: Rahman, Mohammad M., et al.
Publicado: (2020)